Jeffrey Strich
@JeffreyStrichMD
Followers
305
Following
301
Statuses
101
Lasker Clinical Research Scholar National Heart Lung and Blood Institute Critical Care and Infectious Disease Physician Studying Sepsis Views are my own
Joined April 2020
0
0
1
Check out our new manuscript evaluating the impact of R406 on LPS induced neutrophil activation. R406 can inhibit NETosis, ROS, and other end-effector functions of neutrophils that can be detrimental during sepsis! @TheBethesdaLabs @NIHCritCare
2
6
16
0
0
0
RT @NIHClinicalCntr: Congratulations to Kiana Allen for her NIH Postbac presentation! She worked w/ Dr. Jeffrey Strich, M.D. in the NIH Cl…
0
3
0
We (Pathogenesis and Therapeutics Section) are hiring a biologist in the NIH Critical Care Medicine Branch. Great opportunity to investigate the role of myeloid cells in infections that cause critical illness. Link to apply below.
0
5
14
RT @IDSAInfo: IDSA and a coalition of medical professional societies have released recommendations for modifying the Centers for Medicare a…
0
12
0
@SameerKadri12 @morgan_walker4 @NIHCritCare @sarahrenee314 @AlexLawandi @chc_yek @Ahmed_HBabiker Outstanding talk!
0
0
0
RT @ABsteward: 🆕️⚡️⚡️Retrospective cohort 161 US hospitals @JeffreyStrichMD @AlexLawandi @SameerKadri12 Association between pip/tazo MIC &…
0
24
0
RT @NIHCritCare: CCMD faculty @JeffreyStrichMD shared his research findings on the use of fostamatinib in COVID-19 and its potential use ta…
0
3
0
RT @NIHCritCare: Excellent presentation on long COVID with lots of BAL data from Dr. Anthony Suffredini's research lab and the COVID-ARC 19…
0
5
0
@pulmtoilet @GoodishIntent @PulmPEEPs @thanh_neville @msiuba @DrNicoleC @nickmmark @SameerKadri12 @NidaQadirMD @katiewiskar @doc_on_the_run @norfolk_tim @pccm_doc @yourICM @IDSAInfo @IDstewardship How about the person that trained in both ID and CCM @SameerKadri12
1
0
3
RT @JulioHuapayaMD: I am happy to share our paper on the cellular immune response of vaccinated patients with SARS-CoV-2 breakthrough infec…
0
7
0
0
0
1
@ENirenberg SYK is downstream of Fc receptors. We previously demonstrated that fostamatinib inhibits NETosis in COVID and enrolled a P2 study with favorable outcomes. Here we report restoration of myeloid hemostasis with SYK inhibition using samples from the P2 study.
1
5
10
3/3 Thanks to @NIHClinicalCntr @NIAIDNews @TheBethesdaLabs @NIH_NIAMS for the support on this exciting project.
1
0
3